nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—Melatonin—CALR—esophageal cancer	0.0196	0.531	CrCbGaD
Almotriptan—Hypoaesthesia oral—Capecitabine—esophageal cancer	0.0115	0.0385	CcSEcCtD
Almotriptan—Vasospasm—Capecitabine—esophageal cancer	0.00881	0.0294	CcSEcCtD
Almotriptan—Peripheral coldness—Capecitabine—esophageal cancer	0.00632	0.0211	CcSEcCtD
Almotriptan—Sneezing—Capecitabine—esophageal cancer	0.00544	0.0181	CcSEcCtD
Almotriptan—Melatonin—CYP1B1—esophageal cancer	0.00428	0.116	CrCbGaD
Almotriptan—Pain—Carboplatin—esophageal cancer	0.00425	0.0142	CcSEcCtD
Almotriptan—Laryngitis—Capecitabine—esophageal cancer	0.00418	0.0139	CcSEcCtD
Almotriptan—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00393	0.0131	CcSEcCtD
Almotriptan—Body temperature increased—Carboplatin—esophageal cancer	0.00393	0.0131	CcSEcCtD
Almotriptan—Otitis media—Capecitabine—esophageal cancer	0.00387	0.0129	CcSEcCtD
Almotriptan—Neuropathy—Cisplatin—esophageal cancer	0.00384	0.0128	CcSEcCtD
Almotriptan—Eletriptan—CYP2A6—esophageal cancer	0.0038	0.103	CrCbGaD
Almotriptan—Myocardial ischaemia—Capecitabine—esophageal cancer	0.00375	0.0125	CcSEcCtD
Almotriptan—Eye irritation—Capecitabine—esophageal cancer	0.00353	0.0118	CcSEcCtD
Almotriptan—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00333	0.0111	CcSEcCtD
Almotriptan—Melatonin—CYP19A1—esophageal cancer	0.00314	0.0851	CrCbGaD
Almotriptan—Coordination abnormal—Capecitabine—esophageal cancer	0.00307	0.0102	CcSEcCtD
Almotriptan—Neck pain—Capecitabine—esophageal cancer	0.00305	0.0102	CcSEcCtD
Almotriptan—Eletriptan—PTGS1—esophageal cancer	0.00291	0.0789	CrCbGaD
Almotriptan—Colitis—Capecitabine—esophageal cancer	0.00289	0.00964	CcSEcCtD
Almotriptan—Neuropathy—Capecitabine—esophageal cancer	0.00283	0.00942	CcSEcCtD
Almotriptan—Dry eye—Capecitabine—esophageal cancer	0.00278	0.00927	CcSEcCtD
Almotriptan—Breast disorder—Cisplatin—esophageal cancer	0.00268	0.00893	CcSEcCtD
Almotriptan—Mental disability—Capecitabine—esophageal cancer	0.00261	0.00871	CcSEcCtD
Almotriptan—Ear pain—Capecitabine—esophageal cancer	0.00256	0.00854	CcSEcCtD
Almotriptan—Sweating increased—Cisplatin—esophageal cancer	0.0025	0.00832	CcSEcCtD
Almotriptan—Bone disorder—Methotrexate—esophageal cancer	0.00248	0.00827	CcSEcCtD
Almotriptan—Gastroenteritis—Capecitabine—esophageal cancer	0.00247	0.00822	CcSEcCtD
Almotriptan—Abdominal discomfort—Cisplatin—esophageal cancer	0.00246	0.00819	CcSEcCtD
Almotriptan—Eye pain—Capecitabine—esophageal cancer	0.00242	0.00807	CcSEcCtD
Almotriptan—Thirst—Capecitabine—esophageal cancer	0.0023	0.00766	CcSEcCtD
Almotriptan—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00225	0.00751	CcSEcCtD
Almotriptan—Arthritis—Capecitabine—esophageal cancer	0.00225	0.0075	CcSEcCtD
Almotriptan—Myocardial infarction—Cisplatin—esophageal cancer	0.00224	0.00747	CcSEcCtD
Almotriptan—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00224	0.00747	CcSEcCtD
Almotriptan—Conjunctivitis—Cisplatin—esophageal cancer	0.00222	0.0074	CcSEcCtD
Almotriptan—Pain in extremity—Capecitabine—esophageal cancer	0.00219	0.00729	CcSEcCtD
Almotriptan—Diplopia—Capecitabine—esophageal cancer	0.00219	0.00729	CcSEcCtD
Almotriptan—Abdominal pain upper—Capecitabine—esophageal cancer	0.002	0.00665	CcSEcCtD
Almotriptan—Visual impairment—Cisplatin—esophageal cancer	0.00198	0.00659	CcSEcCtD
Almotriptan—Breast disorder—Capecitabine—esophageal cancer	0.00198	0.00658	CcSEcCtD
Almotriptan—Gastritis—Capecitabine—esophageal cancer	0.00193	0.00645	CcSEcCtD
Almotriptan—Muscular weakness—Capecitabine—esophageal cancer	0.00193	0.00643	CcSEcCtD
Almotriptan—Eye disorder—Cisplatin—esophageal cancer	0.00192	0.00639	CcSEcCtD
Almotriptan—Tinnitus—Cisplatin—esophageal cancer	0.00191	0.00637	CcSEcCtD
Almotriptan—Cardiac disorder—Cisplatin—esophageal cancer	0.0019	0.00635	CcSEcCtD
Almotriptan—Immune system disorder—Cisplatin—esophageal cancer	0.00185	0.00618	CcSEcCtD
Almotriptan—Angina pectoris—Capecitabine—esophageal cancer	0.00184	0.00613	CcSEcCtD
Almotriptan—Sweating increased—Capecitabine—esophageal cancer	0.00184	0.00613	CcSEcCtD
Almotriptan—Bronchitis—Capecitabine—esophageal cancer	0.00182	0.00606	CcSEcCtD
Almotriptan—Abdominal discomfort—Capecitabine—esophageal cancer	0.00181	0.00604	CcSEcCtD
Almotriptan—Erythema—Cisplatin—esophageal cancer	0.00179	0.00595	CcSEcCtD
Almotriptan—Sumatriptan—ABCB1—esophageal cancer	0.00175	0.0474	CrCbGaD
Almotriptan—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00172	0.00575	CcSEcCtD
Almotriptan—Hyperglycaemia—Capecitabine—esophageal cancer	0.0017	0.00568	CcSEcCtD
Almotriptan—Vision blurred—Cisplatin—esophageal cancer	0.00168	0.00561	CcSEcCtD
Almotriptan—Tremor—Cisplatin—esophageal cancer	0.00167	0.00558	CcSEcCtD
Almotriptan—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00166	0.00553	CcSEcCtD
Almotriptan—Ill-defined disorder—Cisplatin—esophageal cancer	0.00166	0.00552	CcSEcCtD
Almotriptan—Myocardial infarction—Capecitabine—esophageal cancer	0.00165	0.0055	CcSEcCtD
Almotriptan—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00165	0.0055	CcSEcCtD
Almotriptan—Conjunctivitis—Capecitabine—esophageal cancer	0.00164	0.00546	CcSEcCtD
Almotriptan—Malaise—Cisplatin—esophageal cancer	0.00161	0.00537	CcSEcCtD
Almotriptan—Epistaxis—Capecitabine—esophageal cancer	0.00159	0.0053	CcSEcCtD
Almotriptan—Convulsion—Cisplatin—esophageal cancer	0.00155	0.00516	CcSEcCtD
Almotriptan—Myalgia—Cisplatin—esophageal cancer	0.00152	0.00507	CcSEcCtD
Almotriptan—Rhinitis—Capecitabine—esophageal cancer	0.00152	0.00505	CcSEcCtD
Almotriptan—Anxiety—Cisplatin—esophageal cancer	0.00152	0.00505	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00151	0.00503	CcSEcCtD
Almotriptan—Hypoaesthesia—Capecitabine—esophageal cancer	0.0015	0.00501	CcSEcCtD
Almotriptan—Discomfort—Cisplatin—esophageal cancer	0.0015	0.00501	CcSEcCtD
Almotriptan—Pharyngitis—Capecitabine—esophageal cancer	0.0015	0.005	CcSEcCtD
Almotriptan—Breast disorder—Methotrexate—esophageal cancer	0.00147	0.0049	CcSEcCtD
Almotriptan—Anaphylactic shock—Cisplatin—esophageal cancer	0.00146	0.00486	CcSEcCtD
Almotriptan—Visual impairment—Capecitabine—esophageal cancer	0.00146	0.00486	CcSEcCtD
Almotriptan—Nervous system disorder—Cisplatin—esophageal cancer	0.00143	0.00476	CcSEcCtD
Almotriptan—Tachycardia—Cisplatin—esophageal cancer	0.00142	0.00474	CcSEcCtD
Almotriptan—Eletriptan—ABCB1—esophageal cancer	0.00142	0.0384	CrCbGaD
Almotriptan—Skin disorder—Cisplatin—esophageal cancer	0.00142	0.00472	CcSEcCtD
Almotriptan—Eye disorder—Capecitabine—esophageal cancer	0.00141	0.00471	CcSEcCtD
Almotriptan—Tinnitus—Capecitabine—esophageal cancer	0.00141	0.0047	CcSEcCtD
Almotriptan—Hyperhidrosis—Cisplatin—esophageal cancer	0.00141	0.0047	CcSEcCtD
Almotriptan—Cardiac disorder—Capecitabine—esophageal cancer	0.0014	0.00468	CcSEcCtD
Almotriptan—Immune system disorder—Capecitabine—esophageal cancer	0.00137	0.00455	CcSEcCtD
Almotriptan—Chills—Capecitabine—esophageal cancer	0.00136	0.00452	CcSEcCtD
Almotriptan—Abdominal discomfort—Methotrexate—esophageal cancer	0.00135	0.00449	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00133	0.00443	CcSEcCtD
Almotriptan—Mental disorder—Capecitabine—esophageal cancer	0.00132	0.00442	CcSEcCtD
Almotriptan—Erythema—Capecitabine—esophageal cancer	0.00132	0.00439	CcSEcCtD
Almotriptan—Paraesthesia—Cisplatin—esophageal cancer	0.00131	0.00436	CcSEcCtD
Almotriptan—Dyspnoea—Cisplatin—esophageal cancer	0.0013	0.00433	CcSEcCtD
Almotriptan—Dysgeusia—Capecitabine—esophageal cancer	0.00129	0.0043	CcSEcCtD
Almotriptan—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00128	0.00428	CcSEcCtD
Almotriptan—Back pain—Capecitabine—esophageal cancer	0.00127	0.00424	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00126	0.00419	CcSEcCtD
Almotriptan—Pain—Cisplatin—esophageal cancer	0.00125	0.00415	CcSEcCtD
Almotriptan—Vision blurred—Capecitabine—esophageal cancer	0.00124	0.00413	CcSEcCtD
Almotriptan—Tremor—Capecitabine—esophageal cancer	0.00123	0.00411	CcSEcCtD
Almotriptan—Ill-defined disorder—Capecitabine—esophageal cancer	0.00122	0.00407	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—esophageal cancer	0.00122	0.00406	CcSEcCtD
Almotriptan—Feeling abnormal—Cisplatin—esophageal cancer	0.0012	0.004	CcSEcCtD
Almotriptan—Malaise—Capecitabine—esophageal cancer	0.00119	0.00396	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—esophageal cancer	0.00118	0.00394	CcSEcCtD
Almotriptan—Vertigo—Capecitabine—esophageal cancer	0.00118	0.00394	CcSEcCtD
Almotriptan—Syncope—Capecitabine—esophageal cancer	0.00118	0.00393	CcSEcCtD
Almotriptan—Palpitations—Capecitabine—esophageal cancer	0.00116	0.00388	CcSEcCtD
Almotriptan—Loss of consciousness—Capecitabine—esophageal cancer	0.00116	0.00386	CcSEcCtD
Almotriptan—Body temperature increased—Cisplatin—esophageal cancer	0.00115	0.00384	CcSEcCtD
Almotriptan—Hypertension—Capecitabine—esophageal cancer	0.00114	0.00379	CcSEcCtD
Almotriptan—Chest pain—Capecitabine—esophageal cancer	0.00112	0.00374	CcSEcCtD
Almotriptan—Arthralgia—Capecitabine—esophageal cancer	0.00112	0.00374	CcSEcCtD
Almotriptan—Myalgia—Capecitabine—esophageal cancer	0.00112	0.00374	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—esophageal cancer	0.00112	0.00372	CcSEcCtD
Almotriptan—Anxiety—Capecitabine—esophageal cancer	0.00112	0.00372	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00111	0.00371	CcSEcCtD
Almotriptan—Discomfort—Capecitabine—esophageal cancer	0.00111	0.00369	CcSEcCtD
Almotriptan—Dry mouth—Capecitabine—esophageal cancer	0.0011	0.00365	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—esophageal cancer	0.00108	0.00362	CcSEcCtD
Almotriptan—Confusional state—Capecitabine—esophageal cancer	0.00108	0.00361	CcSEcCtD
Almotriptan—Hypersensitivity—Cisplatin—esophageal cancer	0.00107	0.00358	CcSEcCtD
Almotriptan—Shock—Capecitabine—esophageal cancer	0.00106	0.00352	CcSEcCtD
Almotriptan—Nervous system disorder—Capecitabine—esophageal cancer	0.00105	0.00351	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—esophageal cancer	0.00105	0.00351	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—esophageal cancer	0.00105	0.0035	CcSEcCtD
Almotriptan—Tachycardia—Capecitabine—esophageal cancer	0.00105	0.00349	CcSEcCtD
Almotriptan—Asthenia—Cisplatin—esophageal cancer	0.00105	0.00349	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—esophageal cancer	0.00104	0.00348	CcSEcCtD
Almotriptan—Skin disorder—Capecitabine—esophageal cancer	0.00104	0.00348	CcSEcCtD
Almotriptan—Hyperhidrosis—Capecitabine—esophageal cancer	0.00104	0.00346	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—esophageal cancer	0.00102	0.00339	CcSEcCtD
Almotriptan—Chills—Methotrexate—esophageal cancer	0.00101	0.00337	CcSEcCtD
Almotriptan—Diarrhoea—Cisplatin—esophageal cancer	0.000997	0.00332	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—esophageal cancer	0.000986	0.00329	CcSEcCtD
Almotriptan—Erythema—Methotrexate—esophageal cancer	0.00098	0.00327	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000979	0.00326	CcSEcCtD
Almotriptan—Insomnia—Capecitabine—esophageal cancer	0.000972	0.00324	CcSEcCtD
Almotriptan—Paraesthesia—Capecitabine—esophageal cancer	0.000965	0.00322	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—esophageal cancer	0.00096	0.0032	CcSEcCtD
Almotriptan—Dyspnoea—Capecitabine—esophageal cancer	0.000958	0.00319	CcSEcCtD
Almotriptan—Back pain—Methotrexate—esophageal cancer	0.000948	0.00316	CcSEcCtD
Almotriptan—Dyspepsia—Capecitabine—esophageal cancer	0.000946	0.00315	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000928	0.00309	CcSEcCtD
Almotriptan—Vomiting—Cisplatin—esophageal cancer	0.000927	0.00309	CcSEcCtD
Almotriptan—Fatigue—Capecitabine—esophageal cancer	0.000926	0.00309	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—esophageal cancer	0.000924	0.00308	CcSEcCtD
Almotriptan—Rash—Cisplatin—esophageal cancer	0.000919	0.00306	CcSEcCtD
Almotriptan—Pain—Capecitabine—esophageal cancer	0.000919	0.00306	CcSEcCtD
Almotriptan—Dermatitis—Cisplatin—esophageal cancer	0.000918	0.00306	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—esophageal cancer	0.000909	0.00303	CcSEcCtD
Almotriptan—Feeling abnormal—Capecitabine—esophageal cancer	0.000885	0.00295	CcSEcCtD
Almotriptan—Malaise—Methotrexate—esophageal cancer	0.000884	0.00295	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—esophageal cancer	0.00088	0.00293	CcSEcCtD
Almotriptan—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000879	0.00293	CcSEcCtD
Almotriptan—Nausea—Cisplatin—esophageal cancer	0.000866	0.00289	CcSEcCtD
Almotriptan—Abdominal pain—Capecitabine—esophageal cancer	0.000849	0.00283	CcSEcCtD
Almotriptan—Body temperature increased—Capecitabine—esophageal cancer	0.000849	0.00283	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—esophageal cancer	0.000849	0.00283	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—esophageal cancer	0.000834	0.00278	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—esophageal cancer	0.000834	0.00278	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—esophageal cancer	0.000834	0.00278	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000829	0.00276	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—esophageal cancer	0.000824	0.00275	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—esophageal cancer	0.000806	0.00269	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—esophageal cancer	0.0008	0.00267	CcSEcCtD
Almotriptan—Hypersensitivity—Capecitabine—esophageal cancer	0.000792	0.00264	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—esophageal cancer	0.000784	0.00261	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—esophageal cancer	0.000777	0.00259	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—esophageal cancer	0.000773	0.00258	CcSEcCtD
Almotriptan—Asthenia—Capecitabine—esophageal cancer	0.000771	0.00257	CcSEcCtD
Almotriptan—Pruritus—Capecitabine—esophageal cancer	0.00076	0.00253	CcSEcCtD
Almotriptan—Diarrhoea—Capecitabine—esophageal cancer	0.000735	0.00245	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000729	0.00243	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—esophageal cancer	0.000723	0.00241	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—esophageal cancer	0.000718	0.00239	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—esophageal cancer	0.000713	0.00238	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—esophageal cancer	0.000711	0.00237	CcSEcCtD
Almotriptan—Dizziness—Capecitabine—esophageal cancer	0.00071	0.00237	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—esophageal cancer	0.000704	0.00235	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00069	0.0023	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—esophageal cancer	0.00069	0.0023	CcSEcCtD
Almotriptan—Pain—Methotrexate—esophageal cancer	0.000684	0.00228	CcSEcCtD
Almotriptan—Vomiting—Capecitabine—esophageal cancer	0.000683	0.00228	CcSEcCtD
Almotriptan—Rash—Capecitabine—esophageal cancer	0.000677	0.00226	CcSEcCtD
Almotriptan—Dermatitis—Capecitabine—esophageal cancer	0.000677	0.00226	CcSEcCtD
Almotriptan—Headache—Capecitabine—esophageal cancer	0.000673	0.00224	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—esophageal cancer	0.000659	0.0022	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000654	0.00218	CcSEcCtD
Almotriptan—Nausea—Capecitabine—esophageal cancer	0.000638	0.00213	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—esophageal cancer	0.000632	0.00211	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—esophageal cancer	0.000632	0.00211	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—esophageal cancer	0.000589	0.00196	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—esophageal cancer	0.000574	0.00191	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—esophageal cancer	0.000566	0.00189	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—esophageal cancer	0.000547	0.00182	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—esophageal cancer	0.000529	0.00176	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—esophageal cancer	0.000508	0.00169	CcSEcCtD
Almotriptan—Rash—Methotrexate—esophageal cancer	0.000504	0.00168	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—esophageal cancer	0.000504	0.00168	CcSEcCtD
Almotriptan—Headache—Methotrexate—esophageal cancer	0.000501	0.00167	CcSEcCtD
Almotriptan—Nausea—Methotrexate—esophageal cancer	0.000475	0.00158	CcSEcCtD
Almotriptan—HTR1B—Signaling Pathways—PSME1—esophageal cancer	0.000134	0.000202	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PSME2—esophageal cancer	0.000134	0.000202	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ANXA1—esophageal cancer	0.000134	0.000202	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SST—esophageal cancer	0.000133	0.0002	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP26A1—esophageal cancer	0.000133	0.0002	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000132	0.000199	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SST—esophageal cancer	0.00013	0.000196	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH3—esophageal cancer	0.000129	0.000195	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GHRL—esophageal cancer	0.000129	0.000195	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALOX15—esophageal cancer	0.000129	0.000195	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—NOS3—esophageal cancer	0.000128	0.000193	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FBXW7—esophageal cancer	0.000127	0.000192	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000127	0.000191	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GHRL—esophageal cancer	0.000127	0.000191	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000126	0.000189	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000126	0.000189	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FBXW7—esophageal cancer	0.000125	0.000188	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CA2—esophageal cancer	0.000124	0.000187	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1B1—esophageal cancer	0.000124	0.000187	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000124	0.000187	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000123	0.000186	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TPI1—esophageal cancer	0.000123	0.000186	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTO1—esophageal cancer	0.000123	0.000186	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000121	0.000182	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALDOB—esophageal cancer	0.000118	0.000178	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000118	0.000178	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTGS2—esophageal cancer	0.000117	0.000177	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP19A1—esophageal cancer	0.000117	0.000176	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH2—esophageal cancer	0.000116	0.000175	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000115	0.000174	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000115	0.000174	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA1—esophageal cancer	0.000115	0.000173	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC10A2—esophageal cancer	0.000115	0.000173	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000115	0.000173	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GAPDH—esophageal cancer	0.000114	0.000172	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000114	0.000171	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CRABP1—esophageal cancer	0.000113	0.00017	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000112	0.000168	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADH1B—esophageal cancer	0.00011	0.000166	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GNG7—esophageal cancer	0.000107	0.000162	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TPI1—esophageal cancer	0.000107	0.000161	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.000107	0.000161	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HMOX1—esophageal cancer	0.000107	0.000161	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA2—esophageal cancer	0.000105	0.000159	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TYMP—esophageal cancer	0.000105	0.000159	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000104	0.000157	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000104	0.000157	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFBR2—esophageal cancer	0.000103	0.000155	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000103	0.000155	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP26A1—esophageal cancer	0.000102	0.000154	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCB1—esophageal cancer	0.000102	0.000154	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALDOB—esophageal cancer	0.000102	0.000154	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000101	0.000153	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000101	0.000152	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALDH2—esophageal cancer	0.000101	0.000152	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALOX15—esophageal cancer	9.97e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GAPDH—esophageal cancer	9.84e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADH7—esophageal cancer	9.78e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLCE1—esophageal cancer	9.78e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CRABP1—esophageal cancer	9.75e-05	0.000147	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SMAD4—esophageal cancer	9.74e-05	0.000147	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—EP300—esophageal cancer	9.74e-05	0.000147	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TYMP—esophageal cancer	9.67e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.67e-05	0.000146	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTT1—esophageal cancer	9.56e-05	0.000144	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SMAD4—esophageal cancer	9.54e-05	0.000144	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTO1—esophageal cancer	9.51e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TPI1—esophageal cancer	9.51e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2A6—esophageal cancer	9.45e-05	0.000143	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP26A1—esophageal cancer	9.41e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GNG7—esophageal cancer	9.27e-05	0.00014	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALOX15—esophageal cancer	9.17e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALDOB—esophageal cancer	9.12e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS1—esophageal cancer	8.96e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ENO1—esophageal cancer	8.96e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.88e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA1—esophageal cancer	8.88e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PSME1—esophageal cancer	8.83e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PSME2—esophageal cancer	8.83e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GAPDH—esophageal cancer	8.78e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TPI1—esophageal cancer	8.75e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.75e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CRABP1—esophageal cancer	8.7e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALDH2—esophageal cancer	8.69e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADH1B—esophageal cancer	8.58e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALDOB—esophageal cancer	8.39e-05	0.000127	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GNG7—esophageal cancer	8.28e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTT1—esophageal cancer	8.26e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TYMP—esophageal cancer	8.2e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2A6—esophageal cancer	8.17e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.14e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA2—esophageal cancer	8.12e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GAPDH—esophageal cancer	8.07e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CRABP1—esophageal cancer	8e-05	0.000121	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP26A1—esophageal cancer	7.97e-05	0.00012	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HIF1A—esophageal cancer	7.97e-05	0.00012	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HIF1A—esophageal cancer	7.81e-05	0.000118	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALOX15—esophageal cancer	7.77e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALDH2—esophageal cancer	7.75e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ENO1—esophageal cancer	7.74e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS1—esophageal cancer	7.74e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSME2—esophageal cancer	7.63e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PSME1—esophageal cancer	7.63e-05	0.000115	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KDR—esophageal cancer	7.62e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1B1—esophageal cancer	7.62e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GNG7—esophageal cancer	7.61e-05	0.000115	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.55e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADH7—esophageal cancer	7.55e-05	0.000114	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KDR—esophageal cancer	7.47e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TPI1—esophageal cancer	7.41e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTO1—esophageal cancer	7.41e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTT1—esophageal cancer	7.38e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2A6—esophageal cancer	7.29e-05	0.00011	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.26e-05	0.00011	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CA—esophageal cancer	7.2e-05	0.000109	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH1—esophageal cancer	7.18e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP19A1—esophageal cancer	7.16e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.13e-05	0.000108	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDOB—esophageal cancer	7.11e-05	0.000107	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH1—esophageal cancer	7.03e-05	0.000106	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ENO1—esophageal cancer	6.91e-05	0.000104	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS1—esophageal cancer	6.91e-05	0.000104	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GAPDH—esophageal cancer	6.84e-05	0.000103	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CREBBP—esophageal cancer	6.83e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSME1—esophageal cancer	6.81e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PSME2—esophageal cancer	6.81e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.78e-05	0.000102	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CRABP1—esophageal cancer	6.78e-05	0.000102	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.71e-05	0.000101	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.66e-05	0.0001	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.62e-05	9.98e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1B1—esophageal cancer	6.58e-05	9.93e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—esophageal cancer	6.54e-05	9.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CREBBP—esophageal cancer	6.51e-05	9.82e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GNG7—esophageal cancer	6.45e-05	9.73e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—esophageal cancer	6.4e-05	9.65e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CREBBP—esophageal cancer	6.38e-05	9.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS1—esophageal cancer	6.36e-05	9.59e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ENO1—esophageal cancer	6.36e-05	9.59e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TYMP—esophageal cancer	6.33e-05	9.54e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCB1—esophageal cancer	6.27e-05	9.46e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—esophageal cancer	6.27e-05	9.45e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSME2—esophageal cancer	6.26e-05	9.45e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSME1—esophageal cancer	6.26e-05	9.45e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.19e-05	9.34e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.15e-05	9.28e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—esophageal cancer	6.12e-05	9.23e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CA—esophageal cancer	6.12e-05	9.22e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDH2—esophageal cancer	6.04e-05	9.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALOX15—esophageal cancer	6e-05	9.04e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	5.99e-05	9.03e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.95e-05	8.97e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1B1—esophageal cancer	5.88e-05	8.86e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—esophageal cancer	5.83e-05	8.79e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—esophageal cancer	5.75e-05	8.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.72e-05	8.63e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TPI1—esophageal cancer	5.72e-05	8.63e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—esophageal cancer	5.71e-05	8.61e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2A6—esophageal cancer	5.68e-05	8.57e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.66e-05	8.54e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—esophageal cancer	5.65e-05	8.52e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—esophageal cancer	5.6e-05	8.44e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CA—esophageal cancer	5.55e-05	8.38e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.54e-05	8.36e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP19A1—esophageal cancer	5.53e-05	8.33e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.48e-05	8.27e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—esophageal cancer	5.45e-05	8.22e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	5.44e-05	8.2e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.42e-05	8.18e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.41e-05	8.15e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO1—esophageal cancer	5.39e-05	8.12e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS1—esophageal cancer	5.39e-05	8.12e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	5.34e-05	8.05e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSME1—esophageal cancer	5.31e-05	8e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSME2—esophageal cancer	5.31e-05	8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.28e-05	7.96e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.23e-05	7.89e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.08e-05	7.66e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.04e-05	7.6e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GNG7—esophageal cancer	4.98e-05	7.51e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.95e-05	7.46e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCB1—esophageal cancer	4.84e-05	7.3e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—esophageal cancer	4.82e-05	7.27e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—esophageal cancer	4.72e-05	7.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.66e-05	7.03e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1A—esophageal cancer	4.66e-05	7.03e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—EP300—esophageal cancer	4.65e-05	7.02e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.64e-05	6.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.63e-05	6.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1B1—esophageal cancer	4.58e-05	6.91e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	4.56e-05	6.88e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.45e-05	6.71e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.44e-05	6.69e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EP300—esophageal cancer	4.43e-05	6.69e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.38e-05	6.61e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EP300—esophageal cancer	4.34e-05	6.55e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP19A1—esophageal cancer	4.31e-05	6.49e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CREBBP—esophageal cancer	4.19e-05	6.32e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.16e-05	6.27e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO1—esophageal cancer	4.16e-05	6.27e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.1e-05	6.18e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSME2—esophageal cancer	4.1e-05	6.18e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSME1—esophageal cancer	4.1e-05	6.18e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.93e-05	5.93e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—esophageal cancer	3.86e-05	5.83e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.85e-05	5.81e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—esophageal cancer	3.78e-05	5.71e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—esophageal cancer	3.78e-05	5.7e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.77e-05	5.69e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—esophageal cancer	3.75e-05	5.66e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—esophageal cancer	3.7e-05	5.58e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.66e-05	5.52e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.62e-05	5.47e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.53e-05	5.33e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CA—esophageal cancer	3.44e-05	5.19e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—esophageal cancer	3.43e-05	5.18e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.32e-05	5.01e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	3.28e-05	4.95e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—esophageal cancer	3.24e-05	4.89e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.23e-05	4.88e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	3.21e-05	4.84e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—esophageal cancer	3.17e-05	4.79e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—esophageal cancer	3.11e-05	4.69e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.03e-05	4.57e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.98e-05	4.49e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.97e-05	4.48e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.91e-05	4.39e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—esophageal cancer	2.9e-05	4.37e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—EP300—esophageal cancer	2.86e-05	4.31e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.85e-05	4.3e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—esophageal cancer	2.66e-05	4.02e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.65e-05	3.99e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.52e-05	3.8e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—EP300—esophageal cancer	2.47e-05	3.72e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.44e-05	3.67e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—esophageal cancer	2.26e-05	3.4e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—EP300—esophageal cancer	2.2e-05	3.32e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.11e-05	3.19e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.06e-05	3.11e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—EP300—esophageal cancer	2.03e-05	3.06e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.95e-05	2.93e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.83e-05	2.75e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—esophageal cancer	1.74e-05	2.63e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—EP300—esophageal cancer	1.72e-05	2.59e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.63e-05	2.46e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.59e-05	2.4e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.5e-05	2.26e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—EP300—esophageal cancer	1.32e-05	2e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.27e-05	1.92e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.8e-06	1.48e-05	CbGpPWpGaD
